| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-8,321 | -7,438 | -5,452 | -4,486.52 | -3,039.30 |
|
Research and Development Expenses
|
-26,394 | -18,426 | -14,359 | -6,528.74 | -2,865.85 |
| Depreciation, Amortization and Depletion
|
-5 | -5 | -15 | -5.18 | -258.65 |
| Other Income/Expense, Operating
|
-1,101 | -590 | -572 | -429.47 | -304.70 |
|
Operating Income/Expenses
|
-35,821 | -26,459 | -20,398 | -11,449.92 | -6,468.50 |
|
Total Operating Profit/Loss
|
-35,821 | -26,459 | -20,398 | -11,449.92 | -6,468.50 |
| Total Net Finance Income/Expense
|
1,597 | 1,360 | 1,003 | 855.99 | 48.35 |
| Net Investment Income
|
-232 | 398 | 1,666 | -855.99 | -51.42 |
| Irregular Income/Expenses
|
0 | 0 | -2,905 | -315.44 | -2,214.24 |
|
Other Income/Expense, Non-Operating
|
-- | -- | -- | -- | -37.36 |
|
Non-Operating Income/Expenses, Total
|
1,365 | 1,758 | -236 | -315.44 | -2,217.31 |
|
Pretax Income
|
-34,456 | -24,701 | -20,634 | -11,765.36 | -8,685.81 |
|
Provision for Income Tax
|
-154 | -172 | 0 | 0 | -3.84 |
|
Net Income from Continuing Operations
|
-34,610 | -24,873 | -20,634 | -11,765.36 | -8,689.65 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-34,610 | -24,873 | -20,634 | -11,765.36 | -8,689.65 |
|
Net Income after Non-Controlling/Minority Interests
|
-34,610 | -24,873 | -20,634 | -11,765.36 | -8,689.65 |
|
Net Income Available to Common Stockholders
|
-34,610 | -24,873 | -20,634 | -11,765.36 | -8,689.65 |
|
Diluted Net Income Available to Common Stockholders
|
-34,610 | -24,873 | -20,634 | -11,765.36 | -8,689.65 |
| Basic EPS
|
-1.95 | -1.70 | -2.16 | -1.60 | -2.95 |
| Diluted EPS
|
-1.95 | -1.70 | -2.16 | -1.63 | -2.95 |
|
Basic Weighted Average Shares Outstanding
|
17,394.30 | 14,595.77 | 9,564.86 | 7,200.40 | 2,973.34 |
|
Diluted Weighted Average Shares Outstanding
|
17,394.30 | 14,595.77 | 9,564.86 | 7,200.40 | 2,973.34 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-36,053 | -26,061 | -21,637 | -12,621.34 | -8,734.16 |
|
EBITDA
|
-36,048 | -26,057 | -21,622 | -12,616.16 | -8,475.51 |
|
Normalized EBITDA
|
-32,540 | -23,306 | -18,144 | -9,838.65 | -5,103.88 |
|
Normalized Income
|
-31,628.20 | -22,534.65 | -17,156 | -8,987.85 | -6,509.07 |
|
Total Unusual Items
|
3,508 | 2,751 | 3,478 | 2,777.51 | 3,371.63 |
|
Total Unusual Items Excluding Goodwill
|
3,508 | 2,751 | 3,478 | 2,777.51 | 3,371.63 |
12/31/2022 - 8/3/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade